Last updated: February 9, 2021
Sponsor: Acibadem University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vaginal Cancer
Ovarian Cysts
Ovarian Cancer
Treatment
N/AClinical Study ID
NCT04714931
TRSGO-SLN-OO5
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with Early stage ovarian cancer
Exclusion
Exclusion Criteria:
- Patient who had been administrated chemotherapy prior to surgery
- Patients who had diagnosed with malignancy other than ovarian cancer.
- Patients who had undergone pelvic or paraaortic lymphadenectomy or surgery prior tosurgery.
- Patients who have allergy for the tracers.
Study Design
Total Participants: 200
Study Start date:
January 01, 2021
Estimated Completion Date:
April 01, 2022
Study Description
Connect with a study center
Acibadem MAA University Maslak Hospital
Istanbul, 34457
TurkeyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.